(Total Views: 459)
Posted On: 07/29/2019 1:15:40 PM
Post# of 151

$MRK News Article - European Medicines Agency Adopts Positive Opinion for Merck's KEYTRUDA (pembrolizumab) in Combination with Inlyta (axitinib) as First-Line Treatment for Advanced Renal Cell Carcinoma https://marketwirenews.com/news-releases/euro...50070.html


My Twitter: WhyteStocks